ARCHIVES

ODAC Reviews Post-Marketing Studies for Eight Indications

This article is from The Cancer Letter archive.

Vol. 29 No. 08 | February 21, 2003

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

February 13, 2004

In Brief: Elion, Schein, Johnson Head Societies; Phillips, Salmon Elected; McIntire, Pistenma to Leave NCI

June 3, 1983

Amgen’s Kepivance Approved For Severe Oral Mucositis

January 28, 2005

New Office For Protection Of Research Subjects Formed.

June 23, 2000

Lung Cancer Mortality Begins to decline Among Under 55 Group

April 6, 1990

NCI grants funding: Institute Contemplates Increase In RFA Support Due to Large Number Of Grant Applications

July 9, 1999